Activity of CP 99,219 compared with those of ciprofloxacin, grepafloxacin, metronidazole, cefoxitin, piperacillin, and piperacillin-tazobactam against 489 anaerobes.

類似資料

• Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
  著者:: Pankuch, G A, 等
  出版事項: (1993)
• In vitro activity of the new fluoroquinolone CP-99,219.
  著者:: Neu, H C, 等
  出版事項: (1994)
• Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
  著者:: Wise, R, 等
  出版事項: (1996)
• Dose-ranging study of CP-99,219 (trovafloxacin) for treatment of uncomplicated gonorrhea.
  著者:: Hook, E W, 等
  出版事項: (1996)
• In vitro antimicrobial activity of CP-99,219, a novel azabicyclo-naphthyridone.
  著者:: Gooding, B B, 等
  出版事項: (1993)